Research finds drug candidate slows age-related macular degeneration
Thursday, October 9, 2008 - 12:35
in Health & Medicine
Research results from the Case Western Reserve University School of Medicine show that the progression of age-related macular degeneration (AMD) is markedly slowed in new laboratory-engineered mice when they received treatments of retinylamine, a trial drug that has been tested in a medical school lab. AMD is a leading cause of vision loss in Americans 60 years of age and older.
Read the whole article on Physorg
More from Physorg
Related
- Case Western Reserve University research finds drug candidate slows age-related macular degenerationThu, 9 Oct 2008, 13:36:08 EDT
- Cancer drug is no different in effectiveness as gold standard treatment for macular degenerationFri, 9 Oct 2009, 11:01:32 EDT
- Achieve early diagnosis of ocular pathologies such as keratitis and macular degenerationWed, 25 Nov 2009, 12:16:51 EST
- Experimental therapy may lead to macular degeneration, an international team of researchers cautionWed, 27 Aug 2008, 17:35:46 EDT
- Brain reorganizes to adjust for loss of visionThu, 20 Nov 2008, 12:23:22 EST